The largest database of trusted experimental protocols

5 bromo 2 deoxyuridine brdu

Manufactured by Merck Group
Sourced in United States, Germany, Sao Tome and Principe, United Kingdom, Japan, Macao, Canada

5-bromo-2'-deoxyuridine (BrdU) is a synthetic nucleoside analog that is commonly used as a marker for cellular proliferation. It can be incorporated into the DNA of dividing cells in place of the naturally occurring thymidine. The presence of BrdU in DNA can be detected through various immunohistochemical techniques.

Automatically generated - may contain errors

499 protocols using 5 bromo 2 deoxyuridine brdu

1

Cell Line Maintenance and Neonatal Rat Ventricular Myocyte Isolation

Check if the same lab product or an alternative is used in the 5 most similar protocols
Cell line H9C2 was purchased from ATCC and maintained in Dulbecco’s modified Eagle’s medium (DMEM) with 10% of fetal bovine serum (FBS), penicillin (100 U/mL), and streptomycin (100 μg/mL).
The neonatal rat ventricular myocytes (NRVMs) were isolated and cultured as described previously.22 (link) Briefly, heart tissues from 2-day-old neonatal rats were cut into pieces and digested with 1× PBS containing 0.1% collagenase II and 0.002% DNase to a single-cell suspension, and cultured in DMEM containing 10% FBS, penicillin (100 U/mL), and streptomycin (100 μg/mL). 10 μM 5-bromo-2ʹ-deoxyuridine (BrdU) (Sigma) was applied to the medium to reduce fibroblast content. Additional cardiofibroblasts were removed from cardiomyocytes using differential adhesion. Purified cardiomyocytes were seeded on 0.1% gelatin-coated plates. After 48 h of cultivation, the NRVMs were transfected with indicated miRNA for further analysis.
+ Open protocol
+ Expand
2

Choriocarcinoma Cell Line Protocol

Check if the same lab product or an alternative is used in the 5 most similar protocols
Primary antibodies used in this study were provided by the following sources: SLAMF1 (PA5-96046), Invitrogen (Carlsbad, CA, USA); β-actin (#58169), LC3B (#2775), p62 (#8025), and cleaved Caspase-3 (#9664), Cell Signaling (Danvers, MA, USA). MTX, Monodansylcadaverine (MDC), Bafilomycin A1, 5-bromo-2ʹ-deoxyuridine (BrdU), and 3-Methyladenine (3-MA) were provided by Sigma-Aldrich (St. Louis, MO, USA). Human choriocarcinoma cell lines JEG3 and JAR were provided by ATCC culture collection (Manassas, VA, USA). MTX-resistant JEG3/MTX and JAR/MTX sublines were established as we described previously.13 (link) The use of these choriocarcinoma cell lines in this study was approved by the institutional research ethics committee in Xiangya Hospital, Central South University. These cell lines were routinely grown in Dulbecco’s Modified Eagle’s medium (DMEM) supplemented with 10% fetal bovine serum. Lentiviral plasmids expressing non-targeting scramble or shSLAMF1 were provided by Genecopoeia Inc. (Rockville, MD, USA). Lentiviral plasmids LV105 expressing empty vector or SLAMF1 open reading frames (ORFs) were also provided by Genecopoeia Inc. The production of recombined lentivirus was performed according to the manufacturer’s instruction.13 (link)
+ Open protocol
+ Expand
3

Tβ4 Improves Functional Outcomes in MCAo Rats

Check if the same lab product or an alternative is used in the 5 most similar protocols
Rats subjected to MCAo were randomized into one of 4 groups of 10
animals/group: control, 2, 12 and 18 mg/kg. Tβ4 (RegeneRx
Biopharmaceuticals Inc) was administered IP 24 hrs after MCAo and then every 3
days for 4 additional doses. Randomization was performed by placing labeled tabs
(control, 2, 12 or 18 mg/kg) in a large envelope. A research associate then
placed his/her hand in the envelope to randomly choose a labeled tab. The
selected rat was then assigned this dose. We determined a sample size of ten
rats in each group were required for analysis. Since this study was designed to
observe functional outcome, we only included those rats which completed the
functional tests until time of sacrifice (56 days). These doses were based on
previous toxicology studies performed in rodent, dog and human models (Crockford, 2007 (link)). Moreover, these doses were
chosen because it was likely that this range of dosing will be used in human
clinical studies. For labeling proliferating cells,
5-bromo-2′-deoxyuridine (BrdU, 100 mg/kg; Sigma, St. Louis, MO) was
injected IP into rats 24 hours after MCAo and then daily for 7 days. Rats were
sacrificed 56 days after MCAo to investigate the long term effect of Tβ4
on brain remodeling and functional outcome.
+ Open protocol
+ Expand
4

Cortical Development Immunofluorescence Staining

Check if the same lab product or an alternative is used in the 5 most similar protocols
Perfusion, dissection, and immunofluorescence staining were conducted according to standard protocols as previously described [17 (link)]. The following are the antibodies used: mouse anti-BrdU (1:50 dilution; BD Pharmingen, Franklin Lakes, NJ, USA), rabbit anti-Cux1 (1:100 dilution; Santa Cruz Biotechnology, Dallas, TX, USA), rabbit anti-Phospho-Histone H3 (1:250 dilution; Millipore, Billerica, MA, USA), rabbit anti-Pax 6 (1:500 dilution; Covance, Princeton, NJ, USA), rabbit anti-Tbr2 (1:500 dilution; Abcam, Cambridge, UK), mouse anti-Tuj1 (1:500 dilution; Covance, Princeton, NJ, USA), rabbit anti-Gli3 (1:100 dilution; Santa Cruz Biotechnology, Dallas, TX, USA), and rabbit anti-Cleaved Caspase 3 (1:300 dilution; Cell Signaling, Madison, WI, USA).
For 5-bromo-2-deoxyuridine (BrdU, Sigma, St. Louis, MO, USA) labeling, pregnant dams were treated with 50 μg/g BrdU by intraperitoneal injection for 4 h prior to dissection at E16.5. DiI labeling was conducted by placing small crystals of the lipophilic tracer (1,1′-dioctadecyl-3,3,3′,3′-tetramethylindocarbocyanine; Invitrogen, Waltham, MA, USA) in the neocortex to target the upper layer (2/3) and then remained in 4% paraformaldehyde (PFA). After 6 weeks, brains were sectioned at 100 μm, counterstained with bisbenzimide, mounted, and imaged.
+ Open protocol
+ Expand
5

Thymidine Analogs and VPA in Ferret Pups

Check if the same lab product or an alternative is used in the 5 most similar protocols
Eight naturally-delivered male pups from six pregnant ferrets, which were purchased from Japan SLC (Hamamatsu, Japan), were used in the experiments. The pups were reared with lactating dams (3–5 pups/mother) in stainless steel cages (80 cm × 50 cm × 35 cm) maintained at 21.5 ± 2.5 °C under 12-h artificial illumination in the Facility of Animal Breeding, Nakaizu Laboratory Japan SLC (Izu, Japan). All lactating dams were fed a pellet feed (High-Density Ferret Diet 5L14, PMI Feeds, Inc., St. Louis, MO, USA) and ad libitum tap water.
The thymidine analogs and VPA were administered on a schedule designed according to a previous study [10 (link)]. Eight male pups were intraperitoneally injected with 30 μg/g body weight of 5-ethynyl-2′-deoxyuridine (EdU) (Sigma-Aldrich, St. Louis, MO, USA) at PD 5 and 30 μg/g body weight of 5-bromo-2′-deoxyuridine (BrdU) (Sigma-Aldrich) at PD 7, respectively. Four pups were intraperitoneally administered 200 µg/g body weight of VPA on PDs 6 and 7. Four unexposed pups were used as controls. VPA was injected a second time at the same time as the BrdU injection. On PD 20, all animals were perfused with 4% paraformaldehyde (PFA) (Merck, Darmstadt, Germany)-phosphate buffered saline (PBS) (pH 7.4) under deep anesthesia with ~2% isoflurane gas. The cerebellum was removed and immersed in the same fixative.
+ Open protocol
+ Expand
6

Systemic and Central Injections for Research

Check if the same lab product or an alternative is used in the 5 most similar protocols
Salmon calcitonin (sCT, H-2260; Bachem), pramlintide (SC-476040; Santa Cruz) and liraglutide (gift of NovoNordisk, Denmark) were dissolved in 0.1 M PBS (pH 7.4) for systemic (IP) injections. Amylin (H-9475.100; Bachem), GLP-1 (7–36; H-67951000, Bachem) and Angiotensin II (Ang II: Bachem) were dissolved in artificial cerebrospinal fluid (aCFS; Harvard Apparatus) for central injection. 5′-bromo-2′-deoxyuridine (BrdU; Sigma) was dissolved in double-distilled water and heated to 40–50 °C.
+ Open protocol
+ Expand
7

BrdU Labeling for Cell Proliferation

Check if the same lab product or an alternative is used in the 5 most similar protocols
A single intraperitoneal injection of 50 µg/g body weight 5-bromo-2-deoxyuridine (BrdU; Sigma-Aldrich, Cat. B5002) in physiological saline was administered 1 h prior to perfusion fixation in 4% PFA.
+ Open protocol
+ Expand
8

Quantifying Cell Proliferation Dynamics

Check if the same lab product or an alternative is used in the 5 most similar protocols
To visualize cell proliferation, primary cell cultures were incubated with the nucleotide analog 5-bromo-2′-deoxyuridine (BrdU, 3 μg/ml; Sigma-Aldrich) and a
synthetic estrogen analogue (DES, 1 × 10–8 M; Merck Millipore) for 24 h. The cells were fixed in 4% paraformaldehyde in 25 mM phosphate buffer (pH
7.4) for 20 min at 20–23°C, and then treated with 4 N HCl in PBS for 10 min. Next, the cells were incubated in PBS containing 2% normal donkey serum for 30 min
at 30°C, followed by overnight incubation with rabbit anti-rat BrdU polyclonal antibody and mouse monoclonal anti-CD9 antibody at 22–23°C (Table 1). The cells were then washed with PBS and incubated with PBS containing appropriate secondary antibodies (Table 1). Five random fields per well were imaged using a fluorescence microscope with a 40-fold objective lens. Observations were
performed in triplicate for each experimental group.
+ Open protocol
+ Expand
9

Cellular Proliferation, Motility, and Invasion Assays

Check if the same lab product or an alternative is used in the 5 most similar protocols
5-Bromo-2′-deoxyuridine (BrdU, Sigma-Aldrich Co.) -mediated
proliferation assay was performed as previously (3 (link)). Cell motility was determined by allowing cells to move on the
colloidal gold-covered surface and measuring their migrated tracks, as
previously described (4 (link)). Monolayer
scratch assay was performed as previously described (5 (link)). Invasive phenotype was measured as previously described
(6 (link)). The anchorage independent growth
assay was performed in soft agar as previously described (7 (link)).
+ Open protocol
+ Expand
10

Chromosome-Orientation FISH for Radiation-Induced Instability

Check if the same lab product or an alternative is used in the 5 most similar protocols
Chromosome-orientation fluorescence in situ hybridization (CO-FISH) was employed to evaluate IR-induced chromosomal instability and performed as previously described (62 (link), 70 (link)) with some modification. Following irradiation, cell cultures were incubated for various times, trypsinized, and subcultured into medium containing 5-bromo-2-deoxyuridine (BrdU, 10 μM; Sigma-Aldrich) for one cell cycle. Slides were stained with Hoechst 33258 (0.50 ng/μL; Sigma-Aldrich) for 15 min and exposed to 365 nm UV light (Stratalinker 2400) for 25 min. Following UV exposure, BrdU incorporated strands were digested with Exonuclease III (3 U/μL in provided reaction buffer; Promega) at room temperature for 10 min. Slides were hybridized with a Cy-3 conjugated (TTAGGG)3 PNA telomere probe (0.2 μg/mL; Applied Biosystems) at 37°C for 1.5 h, rinsed in 70% formamide at 32°C for 10 min, and dehydrated in another ethanol series before re-probing at 37°C for 2 h. Following the second hybridization, slides were rinsed with 70% formamide at 32°C for 15 min followed by 5 min rinse in PN buffer. Chromosomes were counterstained with DAPI (4,6-diamidine-2-phenylindole dihydrochloride; Vectashield, Vector Laboratories). Preparations were examined and images captured and analyzed using a Zeiss Axioskop2 Plus microscope equipped with a Photometrics Coolsnap ES2 camera and running Metavue 7.1 software.
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!